Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.65 |
| ▸ | GAA | P10253 | 3/20 | 0.65 |
| ▸ | MAPT | P10636 | 4/20 | 0.63 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15077997 | 1.00 | ALDH1A1 (0.65) | ALDH1A1KDM4EGAAMAPTRAB9A | |
| SCHEMBL15078012 | 1.00 | ALDH1A1 (0.65) | ALDH1A1KDM4EGAAMAPTRAB9A | |
| SCHEMBL13704129 | 0.69 | KDM4E (0.51) | ALDH1A1KDM4EGAAMAPTHSD17B10 | |
| SCHEMBL14583303 | 0.67 | KDM4E (0.54) | ALDH1A1KDM4EGAAMAPTHSD17B10 | |
| SCHEMBL13704088 | 0.66 | KDM4E (0.53) | ALDH1A1KDM4EGAAMAPTHSD17B10 | |
| SCHEMBL13704089 | 0.65 | KDM4E (0.51) | ALDH1A1KDM4EGAAMAPTHSD17B10 | |
| SCHEMBL13704084 | 0.65 | KDM4E (0.51) | ALDH1A1KDM4EGAAMAPTRAB9A | |
| SCHEMBL13333342 | 0.65 | ALDH1A1 (0.71) | ALDH1A1KDM4EGAATSHRHSD17B10 | |
| SCHEMBL14583075 | 0.64 | MEN1 (0.53) | ALDH1A1KDM4EMAPTTSHRUSP2 | |
| SCHEMBL4287642 | 0.64 | MEN1 (0.63) | ALDH1A1KDM4EMAPTUSP2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250319162-A1 | METHODS AND MATERIALS FOR TREATING OBESITY | UNIV CALIFORNIA (US) | 2025-10-16 | — | — | US | claimed |
| US-20250319162-A1 | METHODS AND MATERIALS FOR TREATING OBESITY | UNIV CALIFORNIA (US) | 2025-10-16 | — | — | US | disclosed |
| CN-119375430-A | Odor-based abnormality alert method, apparatus, device, medium, and program product | 霍威克(天津)科技有限公司 | 2025-01-28 | — | — | CN | disclosed |
| US-11964985-B2 | Anti-cancer compounds targeting Ral GTPases and methods of using the same | The Regents of the University of Colorado, a body corporate. (US) | 2024-04-23 | — | — | US | disclosed |
| US-20220411733-A1 | Method and System for Converting Electricity into Alternative Energy Resources | UNIV CHICAGO (US) | 2022-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11964985-B2 | Anti-cancer compounds targeting Ral GTPases and methods of using the same | ARFGAP1, ARHGDIB, IQGAP1 | ALDH1A1 3045/4885KDM4E 1255/4885GAA 1980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.